Climate Change Data

Environmental Metrics

Social Achievements

• Received MDSAP certification in November 2021, expanding its quality management system to the US and Canada.

Governance Achievements

• Established a remuneration policy approved by the annual general meeting of shareholders on May 27, 2021.

Climate Goals & Targets

Environmental Challenges

• The outbreak of the coronavirus (COVID-19) or another infectious disease outbreak or other serious public health problem could lead to delays in Sequana Medical's clinical studies and could negatively impact its supply chain and workforce.
• Sequana Medical is subject to many risks, including those related to global events, clinical development, regulatory approvals, financial situation, and commercialization and reimbursement.
• The Russian invasion of Ukraine could have a destabilizing impact on Sequana Medical's operations, both directly as a result of the conduct of studies in neighboring countries and indirectly through the impact on global macroeconomic conditions.

Mitigation Strategies

• Sequana Medical is continuously improving its treatment with the alfapump, leading to a clear increase in clinical results.
• Sequana Medical has implemented a risk management and control structure in accordance with the Belgian Code of Companies and Associations and the 2020 Belgian Corporate Governance Code.
• Sequana Medical is continuously monitoring the situation regarding the impact of COVID-19 and the geopolitical situation in Ukraine on its ability to secure additional funding rounds or to undertake transactions in the capital market.

Supply Chain Management

Climate-Related Risks & Opportunities

Reporting Standards

Frameworks Used: IFRS

Certifications: MDSAP

Third-party Assurance: PwC Bedrijfsrevisoren BV